Literature DB >> 16777946

Differential effect of troponin T mutations on the inotropic responsiveness of mouse hearts--role of myofilament Ca2+ sensitivity increase.

Syevda G Sirenko1, James D Potter, Björn C Knollmann.   

Abstract

Troponin T (TnT) mutations that cause familial hypertrophic cardiomyopathy (FHC) and sudden cardiac death frequently increase myofilament Ca2+ sensitivity, suggesting that their Ca2+-sensitizing effect contributes importantly to the FHC pathogenesis. To test this hypothesis, we compared transgenic mice expressing the Ca2+-sensitizing TnT-I79N mutant (I79N), which causes a high rate of sudden cardiac death in patients, with mice expressing the more benign TnT-R278C mutant (R278C) that does not affect myofilament Ca2+ sensitivity. Acutely increasing myofilament Ca2+ sensitivity with EMD57033 served as a positive control. Isovolumically contracting hearts were compared over a range of loading conditions (Frank-Starling curve). Consistent with their increased myofilament Ca2+ sensitivity, I79N-Tg hearts demonstrated significantly higher systolic performance at low perfusate [Ca2+] compared with R278C-Tg hearts, which were not statistically different from control hearts expressing either human wild-type TnT or no transgene (CON). Diastolic function was impaired in both FHC mutants (time to 90% relaxation: I79N 48 +/- 1.0 ms, n = 10 or R278C 47 +/- 0.4 ms, n = 7, versus CON 44 +/- 1.0 ms, n = 20, P < 0.05). In the presence of isoproterenol, almost all contractile parameters of R278C hearts became indistinguishable from control hearts, whereas both systolic and diastolic function of I79N hearts significantly worsened (end-diastolic pressure: I79N 20 +/- 4 mmHg versus CON 13 +/- 2 mmHg or R278C 11 +/- 2 mmHg, P < 0.05). The Ca2+ sensitizer EMD57033 produced an even greater contractile dysfunction than the I79N mutation at fast pacing rates. In vivo, maximal exercise tolerance was significantly impaired only in I79N mice. Pretreatment with beta-adrenergic receptor antagonists abolished differences in exercise tolerance. In conclusion, the Ca2+-sensitizing effects of TnT mutations may reduce the responsiveness of mouse hearts to inotropic stimuli.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16777946      PMCID: PMC1819413          DOI: 10.1113/jphysiol.2006.107557

Source DB:  PubMed          Journal:  J Physiol        ISSN: 0022-3751            Impact factor:   5.182


  37 in total

1.  Validation of different methods to compare isovolumic cardiac function in isolated hearts of varying sizes.

Authors:  H Strömer; A Cittadini; G Szymanska; C S Apstein; J P Morgan
Journal:  Am J Physiol       Date:  1997-01

2.  Computer programs for calculating total from specified free or free from specified total ionic concentrations in aqueous solutions containing multiple metals and ligands.

Authors:  A Fabiato
Journal:  Methods Enzymol       Date:  1988       Impact factor: 1.600

3.  Haemodynamics as a determinant of the pharmacokinetics of and the plasma catecholamine responses to isoprenaline.

Authors:  J Ludwig; T Halbrügge; G Vey; J Walter; K H Graefe
Journal:  Eur J Clin Pharmacol       Date:  1989       Impact factor: 2.953

4.  beta-Receptors and contractile reserve in left ventricular hypertrophy.

Authors:  M H Ayobe; R C Tarazi
Journal:  Hypertension       Date:  1983 Mar-Apr       Impact factor: 10.190

5.  Stereoselective actions of thiadiazinones on canine cardiac myocytes and myofilaments.

Authors:  R J Solaro; G Gambassi; D M Warshaw; M R Keller; H A Spurgeon; N Beier; E G Lakatta
Journal:  Circ Res       Date:  1993-12       Impact factor: 17.367

6.  Intracellular calcium handling in isolated ventricular myocytes from patients with terminal heart failure.

Authors:  D J Beuckelmann; M Näbauer; E Erdmann
Journal:  Circulation       Date:  1992-03       Impact factor: 29.690

Review 7.  Modulation of noradrenaline release through activation of presynaptic beta-adrenoreceptors.

Authors:  H Majewski
Journal:  J Auton Pharmacol       Date:  1983-03

8.  A new cardiotonic drug reduces the energy cost of active tension in cardiac muscle.

Authors:  T Gross; I Lues; J Daut
Journal:  J Mol Cell Cardiol       Date:  1993-03       Impact factor: 5.000

9.  Differential effects of the optical isomers of EMD 53998 on contraction and cytoplasmic Ca2+ in isolated ferret cardiac muscle.

Authors:  J White; J A Lee; N Shah; C H Orchard
Journal:  Circ Res       Date:  1993-07       Impact factor: 17.367

10.  Myoplasmic free calcium concentration reached during the twitch of an intact isolated cardiac cell and during calcium-induced release of calcium from the sarcoplasmic reticulum of a skinned cardiac cell from the adult rat or rabbit ventricle.

Authors:  A Fabiato
Journal:  J Gen Physiol       Date:  1981-11       Impact factor: 4.086

View more
  18 in total

Review 1.  Hypertrophic cardiomyopathy: from genetics to treatment.

Authors:  Ali J Marian
Journal:  Eur J Clin Invest       Date:  2010-04       Impact factor: 4.686

2.  Myofilament Ca sensitization increases cytosolic Ca binding affinity, alters intracellular Ca homeostasis, and causes pause-dependent Ca-triggered arrhythmia.

Authors:  Tilmann Schober; Sabine Huke; Raghav Venkataraman; Oleksiy Gryshchenko; Dmytro Kryshtal; Hyun Seok Hwang; Franz J Baudenbacher; Björn C Knollmann
Journal:  Circ Res       Date:  2012-05-29       Impact factor: 17.367

Review 3.  Proteasome dysfunction in cardiomyopathies.

Authors:  Jennifer E Gilda; Aldrin V Gomes
Journal:  J Physiol       Date:  2017-03-16       Impact factor: 5.182

Review 4.  Myocardial energy depletion and dynamic systolic dysfunction in hypertrophic cardiomyopathy.

Authors:  Julian O M Ormerod; Michael P Frenneaux; Mark V Sherrid
Journal:  Nat Rev Cardiol       Date:  2016-07-14       Impact factor: 32.419

5.  Diltiazem prevents stress-induced contractile deficits in cardiomyocytes, but does not reverse the cardiomyopathy phenotype in Mybpc3-knock-in mice.

Authors:  Frederik Flenner; Birgit Geertz; Silke Reischmann-Düsener; Florian Weinberger; Thomas Eschenhagen; Lucie Carrier; Felix W Friedrich
Journal:  J Physiol       Date:  2017-02-07       Impact factor: 5.182

6.  Ca(2+)-regulatory function of the inhibitory peptide region of cardiac troponin I is aided by the C-terminus of cardiac troponin T: Effects of familial hypertrophic cardiomyopathy mutations cTnI R145G and cTnT R278C, alone and in combination, on filament sliding.

Authors:  Nicolas M Brunet; P Bryant Chase; Goran Mihajlović; Brenda Schoffstall
Journal:  Arch Biochem Biophys       Date:  2014-01-10       Impact factor: 4.013

7.  Chronic Calmodulin-Kinase II Activation Drives Disease Progression in Mutation-Specific Hypertrophic Cardiomyopathy.

Authors:  Sarah J Lehman; Lauren Tal-Grinspan; Melissa L Lynn; Joshua Strom; Grace E Benitez; Mark E Anderson; Jil C Tardiff
Journal:  Circulation       Date:  2019-03-19       Impact factor: 29.690

8.  The role of Akt/GSK-3beta signaling in familial hypertrophic cardiomyopathy.

Authors:  Stephen W Luckey; Lori A Walker; Tyson Smyth; Jason Mansoori; Antke Messmer-Kratzsch; Anthony Rosenzweig; Eric N Olson; Leslie A Leinwand
Journal:  J Mol Cell Cardiol       Date:  2009-02-21       Impact factor: 5.000

9.  Differential interactions of thin filament proteins in two cardiac troponin T mouse models of hypertrophic and dilated cardiomyopathies.

Authors:  Raffaella Lombardi; Achim Bell; Vinitha Senthil; Jasvinder Sidhu; Michela Noseda; Robert Roberts; Ali J Marian
Journal:  Cardiovasc Res       Date:  2008-03-18       Impact factor: 10.787

10.  Familial hypertrophic cardiomyopathy: is the Frank-Starling law kaput?

Authors:  Sabine Huke; Björn C Knollmann
Journal:  Circ Res       Date:  2013-05-24       Impact factor: 17.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.